We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Cryotherapy for Benign Breast Lumps

By HospiMedica staff writers
Posted on 05 Jan 2004
A study has found cryotherapy a safe and effective office-based treatment for reducing benign breast lumps.

The ultrasound-guided procedure uses exceptionally cold temperatures to freeze and kill abnormal tissue. More...
After the breast tissue is numbed around the mass, doctors insert a cryoprobe, similar to a large needle, into the middle of the lesion. An ice ball forms at the tip of the probe and continues to grow until the ultrasound confirms that the entire lump has been engulfed, killing the tissue.

The procedure offers three advantages, according to lead author Peter J. Littrup, M.D., professor of radiology, urology, and radiation oncology at Wayne State University (Detroit, MI, USA). Ice is easily visualized with both ultrasound and computed tomography (CT), and cryotherapy is virtually painless when the area around the tumor is numbed with a local anesthetic. The third benefit is the outcome. "Cryotherapy preserves the breast's supporting architecture, or collagen, and does not leave significant surgical scars,” said Dr. Littrup, who presented the study at the annual meeting of the Radiological Society of North America in Chicago (IL, USA).

Researchers treated 42 fibroadenomas in 27 patients with ultrasound-guided cryotherapy to evaluate outcomes and patient acceptance of cryotherapy instead of surgical removal. On average, the fibroadenomas were reduced by 73%, with no significant complications. Patients were pleased with the cosmetic results.




Related Links:
Wayne State

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.